Search

Boehringer Ingelheim Announces Jean-Michel Boers as U.S. Country Managing Director, President & CEO Effective August 1, 2020; Dr. Wolfgang Baiker to Retire

Confronting health disparities in clinical trials

As a research-driven pharmaceutical company, one of our priorities is to ensure there’s more representation from underserved communities, particularly for clinical cancer trials.

Lars Dreesmann Named President of Boehringer Ingelheim Fremont, Inc.

Protecting Humans & Animals | COVID-19 | Boehringer Ingelheim US

Read more on Boehringer Ingelheim's commitment to protecting both humans and animals during the COVID-19 pandemic.

Transition to renewable energy signals a broader commitment to environmental sustainability

The Core of our Leitbild

Click here to find out more about Boehringer Ingelheim's core values and mission statement, highlighting our key business focuses.

Fremont, California

Boehringer Ingelheim’s Fremont, California facility in the San Francisco Bay

Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies

Koropi

With its presence in Greece of more than a half century, Boehringer Ingelheim inaugurated the production facility in Koropi in 1975.

Boehringer Ingelheim announces nintedanib expanded access program (EAP) for children and adolescents with fibrosing interstitial lung disease

Striving to revolutionize mental health research

World Mental Health Day: We are committed to transforming the mental health landscape through precision psychiatry

BI Awards Showcase Veterinary Talent | Boehringer Ingelheim US

Click here to read more on the Boehringer Ingelheim annual awards showcasing and celebrating emerging veterinary talent across the USA.

BI Cares Financial Contributions Program: Strengthening Communities

Discovery Research Global Post-Doc Program

Immunology

Words of Health and Hope

Click here to hear from our patients, who have expressed to us in beautifully written thank you notes for our BI Cares Patient Assistance Program.

Welcome to the Neuroscience Gallery | Boehringer Ingelheim US

Click here to take a guided tour through our Neuroscience virtual 3-D art exhibition, helping us to improve how we diagnose and treat various diseases.

Fornovo San Giovanni (Bidachem)

Founded in 1981, Fornovo San Giovanni serves both – Human Pharma and Animal Health

Kobe

The Kobe Pharma Research Institute takes part in the global research and development activities for human pharmaceuticals.

Full results from EMPERIAL exercise ability trials presented

Why cancer care is personal for us

At Boehringer Ingelheim, we have made a generational commitment to transforming cancer care, with the ultimate goal of curing a range of cancers.

Volunteering to Strengthen the Human-Animal Bond

Ingelheim

The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany.

Clinical Pharmacology

Boehringer Ingelheim is proud to offer a new two-year fellowship within Clinical Pharmacology. Click here to find out more.

Cardio-Renal-Metabolic diseases

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers